Local News: Cottage Grove, OR 

 | 

Sign Up

 | 

Sign In

Advertisment

Risperdal, Risperidone

Risperdal, Risperidone News Editors

RoboBlogger

I edit this news page on Topix when no humans are available to help.

People just like you make Risperdal, Risperidone News on Topix better every day. If you're interested in becoming an editor, apply today!

Edits History | Editor Blog

RSS icon mobile icon

Risperdal, Risperidone News

News on Risperdal, Risperidone (generic) continually updated from thousands of sources around the net.

Thursday Nov 5 | Nature Publishing Group

Early Response to Antipsychotic Drug Therapy as a Clinical Marker of...

Previous Presentation: These data debuted at the annual American Psychiatric Association congress in Washington, DC, May 3-8, 2008.

Comment?

Related Topix: Biotech, Medicine, Eli Lilly, Healthcare Industry, Indianapolis, IN, Medication, Schizophrenia, Health, Zyprexa, Zydis, Olanzapine (generic)

Tue Nov 03, 2009

Lacombe Globe

Living with schizophrenia

There are approximately 30,000 Albertans living with schizophrenia, including many right here in Central Alberta.

Comment?

Related Topix: Medicine, Medication

Mon Nov 02, 2009

Archives General Psychiatry

Original Contribution: Cardiometabolic Risk of Second-Generation...

Context Cardiometabolic effects of second-generation antipsychotic medications are concerning but have not been sufficiently studied in pediatric and adolescent patients naive to antipsychotic medication.

Comment?

Related Topix: Queens, NY, New York, NY, Medicine, Zyprexa, Zydis, Olanzapine (generic), Medication

Sat Oct 31, 2009

EMaxHealth

Rapid Weight Gain in Children Linked to Common Psychiatric Meds

Researchers at Zucker Hillside Hospital in Glen Oaks NY have found a link to substantial weight gain and hypercholesterolemia in children and adolescents taking many common psychiatric medications.

Comment?

Related Topix: Glen-Oaks, NY, Medicine, Zyprexa, Zydis, Olanzapine (generic), Medication, Seroquel, Quetiapine (generic), Abilify, Aripiprazola (generic), Bipolar Disorder, Health

Fri Oct 30, 2009

Medical News Today

Antipsychotic Drugs Linked To Significant Weight Gain In Children And Teenagers

Featured Article Main Category: Psychology / Psychiatry Also Included In: Pediatrics / Children's Health ; Mental Health ; Obesity / Weight Loss / Fitness Article Date: 29 Oct 2009 - 11:00 PDT US researchers found that many children and teenagers treated with second generation antipsychotic drugs put on a significant amount of weight and also ...

Comment?

Related Topix: Medicine, Hospital Administration, Healthcare Industry, Glen-Oaks, NY, Manhasset, NY, Zyprexa, Zydis, Olanzapine (generic), Medication, Health

Thu Oct 29, 2009

CNN

Schizophrenia drugs in kids cause weight gain

Drugs called atypical antipsychotics caused kids to gain an average of 10 to 19 pounds in the first few months.

Comment?

Related Topix: Schizophrenia, Medicine, Health, Family, Kids, Zyprexa, Zydis, Olanzapine (generic), Medication, Food and Drug Administration, ADHD

US News & World Report

Psychiatric Meds Can Bring on Rapid Weight Gain in Kids

Many young children and adolescents taking drugs for severe psychiatric problems gain substantial weight and, in some cases, show increased levels of LDL cholesterol and triglycerides in their blood, researchers report in the Oct.

Comment?

Related Topix: Family, Kids, Schizophrenia, Medicine, Health, Zyprexa, Zydis, Olanzapine (generic), Medication, Seroquel, Quetiapine (generic), Abilify, Aripiprazola (generic)

Drugs.com

Use of Antipsychotic Medications by Children and Adolescents Associated With Significant Weight Gain

Many pediatric and adolescent patients who received second-generation antipsychotic medications experienced significant weight gain, along with varied adverse effects on cholesterol and triglyceride levels and other metabolic measures, according to a study in the October 28 issue of JAMA .

Comment?

Related Topix: Medicine, Hospital Administration, Healthcare Industry, Glen-Oaks, NY, Manhasset, NY, Zyprexa, Zydis, Olanzapine (generic), Medication

Wed Oct 28, 2009

The Post Chronicle

Antipsychotics Cause Rapid Weight Gain In Youth

Up to a third of children and adolescents who took common antipsychotic drugs for the first time became overweight or obese in as little as 11 weeks, raising their risk for diabetes and heart disease, U.S. researchers said on Tuesday.

Comment?

Related Topix: Medicine, Diabetes, Health, Hospital Administration, Healthcare Industry, Medication, Zyprexa, Zydis, Olanzapine (generic), Abilify, Aripiprazola (generic), Seroquel, Quetiapine (generic)

Mon Oct 19, 2009

New Scientist

Stop giving antipsychotics to people with dementia

ARE we too quick to prescribe psychotropic medication for emotional and behavioural problems? Take Alzheimer's disease.

1 comment

Related Topix: Dementia, Health, Alzheimer's, Zyprexa, Zydis, Olanzapine (generic), Medication

Sun Oct 18, 2009

Chemical and Engineering News

Rising To The Challenge

In biotech, a culture of creativity and team building helps top companies to work for weather a tough economy Linda Wang Lexicon Pharmaceuticals TEAMWORK Employees at Lexicon Pharmaceuticals participate in a variety of extracurricular activities, including this dragon-boat race in The Woodlands, Texas.

Comment?

Related Topix: The Woodlands, TX, Biotech, Medicine, Healthcare Industry, Alkermes, Diabetes, Health, Medication, Eli Lilly, 9

Tue Oct 13, 2009

BioWorld

Vanda Inks $465M Novartis Deal, but Acquisition Not off the Table

Five months after the surprise FDA approval of schizophrenia drug Fanapt , Vanda Pharmaceuticals Inc.

Comment?

Related Topix: Biotech, Novartis, Schizophrenia, Medicine, Health, Healthcare Industry, Rockville, MD, Marketing, Medication

Drugs.com

Johnson & Johnson Reports 2009 Third-Quarter Results:

New Brunswick, NJ Johnson & Johnson today announced sales of $15.1 billion for the third quarter of 2009, a decrease of 5.3% as compared to the third quarter of 2008.

Comment?

Related Topix: Biotech, Johnson and Johnson, Medicine, Healthcare Industry, New Brunswick, NJ, Medication, Food and Drug Administration

Wed Sep 30, 2009

Business Standard

Dr Reddy's recalls 4 products from US

Dr Reddy's Laboratories has recalled some batches of four products from its key US market that were observed to contain some oversized tablets.

Comment?

Related Topix: Biotech, Dr Reddys Laboratories, Medicine, Allegra, Fexofenadine (generic), Medication, Pravachol, Pravastatin (generic), Depression, Health, Hay Fever

Tue Sep 29, 2009

CiteULike

Why Olanzapine Beats Risperidone, Risperidone Beats Quetiapine, and...

Why Olanzapine Beats Risperidone, Risperidone Beats Quetiapine, and Quetiapine Beats Olanzapine: An Exploratory Analysis of Head-to-Head Comparison Studies of Second-Generation Antipsychotics Export Am J Psychiatry , Vol.

Comment?

Related Topix: Medicine, Medication, Zyprexa, Zydis, Olanzapine (generic), Schizophrenia, Health

Wed Sep 23, 2009

GlobeNewswire

EAGLE Trial Signals Breakthrough in the Treatment of Schizophrenia

Following our previous press release announcing that BL-1020 has successfully met its primary and secondary efficacy endpoints from the phase 2b EAGLE trial, we are pleased to report positive final results regarding the effects of BL-1020 on cognition.

Comment?

Related Topix: Medicine, Medication

Mon Sep 07, 2009

Domain-B

Aurobindo Pharma receives USFDA, Swissmedic approval for drugs

Aurobindo Pharma has received the final approval for its Risperidone Oral Solution 1mg/mL from the US Food and Drug Administration .

Comment?

Related Topix: Medicine, Medication, Food and Drug Administration

Sat Aug 29, 2009

The Boston Globe

J&J ends work on drug with Alkermes

Alkermes makes Risperdal Consta and other drugs. Shares of Alkermes Inc. declined after the Cambridge biotech said some Johnson & Johnson units have decided not to continue working on a joint venture to develop a four-week version of the antipsychotic drug Risperidone.

Comment?

Related Topix: Biotech, Food, Medicine, J and J Snack Foods, Healthcare Industry, Alkermes, Medication, Johnson and Johnson

Thu Aug 27, 2009

Drugs.com

Filing: Ortho-McNeil Drops Injectable Risperdone Development.

Alkermes said in an SEC filing J&J unit Ortho-McNeil Janssen Pharmaceuticals it will not pursue further development of an injectable formulation of risperidone.

Comment?

Related Topix: Biotech, Medicine, Healthcare Industry, Alkermes, Food, J and J Snack Foods, Medication

Fri Aug 14, 2009

NorthJersey.com

Schering-Plough gets FDA approval for schizophrenia/bi-polar disorder drug

Schering-Plough Corp.'s new drug for schizophrenia and bipolar disorder, Saphris, has been approved by the Food and Drug Administration, the company said Friday.

Comment?

Related Topix: Schizophrenia, Medicine, Health, Food and Drug Administration, Kenilworth, NJ, Abilify, Aripiprazola (generic), Geodon, Ziprasidone (generic), Medication

Also on Topix